Cetera Investment Advisers’s BlackRock Health Sciences Trust BME Stock Holding History

Cetera Investment Advisers’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$550K	Sell	12,815 -391	-3%	-$15.5K	﹤0.01%	3608
2026 Q1	$509K	Sell	13,206 -12	-0.1%	-$495	﹤0.01%	3502
2025 Q4	$544K	Buy	13,218 +1,478	+13%	+$58.4K	﹤0.01%	3361
2025 Q3	$437K	Sell	11,740 -466	-4%	-$16.9K	﹤0.01%	3486
2025 Q2	$445K	Sell	12,206 -208	-2%	-$7.54K	﹤0.01%	3054
2025 Q1	$480K	Buy	12,414 +546	+5%	+$21.7K	﹤0.01%	2879
2024 Q4	$450K	Sell	11,868 -510	-4%	-$20.4K	﹤0.01%	2770
2024 Q3	$519K	Sell	12,378 -803	-6%	-$33.3K	﹤0.01%	2620
2024 Q2	$538K	Sell	13,181 -652	-5%	-$26K	﹤0.01%	2537
2024 Q1	$573K	Buy	+13,833	New	+$579K	﹤0.01%	2501

Other funds holding BME

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.15B AUM 12.28% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Cetera Investment Advisers's BME Position: Q2 2026 in Review

Cetera Investment Advisers reduced its BlackRock Health Sciences Trust (BME) stake by 3% in Q2 2026, selling an estimated $15.5K and leaving 12,815 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #3608.

Cetera Investment Advisers first reported a position in BME in Q1 2024 and has held it in 10 quarters since. The position peaked at $573K in Q1 2024. 78 funds tracked by Wall St. Rank hold BME as of Q2 2026.

Cetera Investment Advisers held 12,815 shares of BlackRock Health Sciences Trust worth $550K as of Q2 2026.
Cetera Investment Advisers sold 391 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $15.5K.
BlackRock Health Sciences Trust made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #3608 holding.
Cetera Investment Advisers first reported a position in BlackRock Health Sciences Trust in Q1 2024 and has held it in 10 quarters since.
Cetera Investment Advisers's BlackRock Health Sciences Trust position peaked at $573K in Q1 2024.
78 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.